Search results for "Editor"

showing 10 items of 844 documents

Estrogenic regulation of skeletal muscle proteome : a study of premenopausal women and postmenopausal MZ cotwins discordant for hormonal therapy

2017

Female middle age is characterized by a decline in skeletal muscle mass and performance, predisposing women to sarcopenia, functional limitations, and metabolic dysfunction as they age. Menopausal loss of ovarian function leading to low circulating level of 17b-estradiol has been suggested as a contributing factor to aging-related muscle deterioration. However, the underlying molecular mechanisms remain largely unknown and thus far androgens have been considered as a major anabolic hormone for skeletal muscle. We utilized muscle samples from 24 pre- and postmenopausal women to establish proteome-wide profiles, associated with the difference in age (30–34 years old vs. 54– 62 years old), men…

0301 basic medicineAgingnaisetlabel‐free protein quantitationProteomeAnabolismvaihdevuodetmedicine.medical_treatmentTwinsmenopausenano‐LC‐HD‐MSElihakset0302 clinical medicineSTRENGTHBRAIN315 Sport and fitness sciencesta315luustoINHIBITORHormone replacement therapy (menopause)ta3142MITOCHONDRIAL BIOGENESISMiddle AgedPostmenopauseMenopauseREPLACEMENThormone replacement therapyEditorialmedicine.anatomical_structurehormonihoitoHormonal therapyOriginal ArticleFemalemuscleswomenAdultestrogeenitnano-LC-HD-MSEEXPRESSIONmedicine.medical_specialtyBiologyestrogenic regulation03 medical and health sciencesmitochondrial functionInternal medicinemedicineHumansMuscle Skeletallabel-free protein quantitationmuscle proteomeAgedSkeletal muscleEstrogenslabel-free proteinquantitationOriginal ArticlesCell Biologyfunctional annotationmedicine.diseaseMiddle ageMONOZYGOTIC TWIN PAIRS030104 developmental biologyEndocrinologyPremenopauselihasmassaSarcopeniaCELLS3111 BiomedicineEnergy Metabolismfemale muscle030217 neurology & neurosurgeryskeletal musclesHormone
researchProduct

Editorial for Special Issue “Bioactive Oxadiazoles”

2021

Oxadiazoles are electron-poor, five-membered aromatic heterocycles containing one oxygen and two nitrogen atoms [...]

0301 basic medicineAnti-Inflammatory AgentsCatalysislcsh:ChemistryInorganic Chemistry03 medical and health sciences0302 clinical medicineIsomerismCoordination ComplexesOrganic chemistryCyclooxygenase InhibitorsPhysical and Theoretical Chemistrylcsh:QH301-705.5Molecular BiologySpectroscopyOxadiazolesChemistryOrganic ChemistryGeneral MedicineComputer Science ApplicationsEditorialn/a030104 developmental biologylcsh:Biology (General)lcsh:QD1-999030220 oncology & carcinogenesisIntroductory Journal ArticleInternational Journal of Molecular Sciences
researchProduct

Untargeted Antifungal Treatment in Nonneutropenic Critically Ill Patients: Should Further Studies Be Performed Based on Trial Sequential Analysis Res…

2018

0301 basic medicineAntifungalmedicine.medical_specialtyAntifungal Agentsempirical treatmentmedicine.drug_classCritical Illness030106 microbiologyNetwork Meta-AnalysisAntifungal drug03 medical and health sciencesMedicineHumansPharmacology (medical)untargeted treatmentEconomics PharmaceuticalIntensive care medicineLetter to the EditorCandida spp.Pharmacologyantifungal drugCritically illbusiness.industryprophylaxiEmpirical treatmentInfectious DiseasesMycosesCandida sppbusiness
researchProduct

The Interplay between Metabolism, PPAR Signaling Pathway, and Cancer

2017

0301 basic medicineArticle SubjectCancerMetabolismBiologymedicine.diseasePPAR signaling pathway03 medical and health sciences030104 developmental biology0302 clinical medicineEditoriallcsh:Biology (General)030220 oncology & carcinogenesisDrug DiscoverymedicineCancer researchPharmacology (medical)lcsh:QH301-705.5PPAR Research
researchProduct

Diabetes and Metabolism Disorders Medicinal Plants: A Glance at the Past and a Look to the Future 2018

2018

0301 basic medicineArticle SubjectTraditional medicinelcsh:Other systems of medicineBiologylcsh:RZ201-999medicine.diseaseMetabolism disorder03 medical and health sciencesEditorial030104 developmental biologyComplementary and alternative medicineDiabetes mellitusmedicineMedicinal plantsEvidence-Based Complementary and Alternative Medicine
researchProduct

Dual Function Molecules and Processes in Cell Fate Decision: A Preface to the Special Issue

2020

A lot of water has passed under the bridge since 1999, when C.J. Jeffery stated in a pioneering review that “the idea of one gene-one protein-one function has become too simple” [...]

0301 basic medicineBiologyCatalysisInorganic Chemistrylcsh:Chemistry03 medical and health sciences0302 clinical medicineSettore BIO/10 - BiochimicaAnimalsHumanscell fate decisionPhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5SpectroscopyDual functiondouble-faced molecules and processesOrganic ChemistryGene Expression Regulation DevelopmentalCell DifferentiationGeneral MedicineComputer Science Applications030104 developmental biologyEditorialn/alcsh:Biology (General)lcsh:QD1-999030220 oncology & carcinogenesisNeuroscienceSignal TransductionInternational Journal of Molecular Sciences
researchProduct

Direct and Inverse Comorbidities Between Complex Disorders

2016

Comorbidity and multimorbidity, defined as the presence of more than one disease in individuals, have emerged as a major challenge in the last decade (Valderas et al., 2009). Indeed, researchers, health professionals, healthcare managers and policy makers, and patients and citizens are lagging behind considering the comorbidity scenario, as illustrated by the paucity of documentation concerning interventions in people with multiple conditions (Smith et al., 2012). There is a clear need to better understand disease-disease relationships, in order to better organize and provide care, but also to develop appropriate research models. We can first characterize direct multimorbidity (higher-than-…

0301 basic medicineBiopsychosocial modelNosologymedicine.medical_specialtymedicinemultimorbidityPhysiologymalaltiesContext (language use)Disease03 medical and health sciencesPhysiology (medical)MultimorbidityMedicinecomplex diseasesPsychiatryOMICS dataComputingMilieux_MISCELLANEOUSbusiness.industrymedicine.diseaseComorbidity[SDV.BIBS]Life Sciences [q-bio]/Quantitative Methods [q-bio.QM]3. Good healthcomorbidityEditorial030104 developmental biologyAge of onsetbusinessNeurocognitive
researchProduct

Differential distribution and enrichment of non-coding RNAs in exosomes from normal and Cancer-associated fibroblasts in colorectal cancer.

2018

Exosome production from cancer-associated fibroblasts seems to be an important driver of tumor progression. We report the first in-depth biotype characterization of ncRNAs, analyzed by Next Generation Sequencing and Bioinformatics, expressed in established primary human normal and cancer-associated fibroblasts (CAFs) from cancer and normal mucosa tissues from 9 colorectal cancer patients, and/or packaged in their derived exosomes. Differential representation and enrichment analyses based on these ncRNAs revealed a significant number of differences between the ncRNA content of exosomes and the expression patterns of the normal and cancer-associated fibroblast cells. ncRNA regulatory elements…

0301 basic medicineCancer ResearchStromal cellRNA UntranslatedColorectal cancerBiologyExosomeslcsh:RC254-282Non-coding RNAs03 medical and health sciencesCancer-Associated FibroblastsCell MovementNext generation sequencingmedicineBiomarkers TumorHumansLiquid biopsyLetter to the EditorCells CulturedCell ProliferationTumor microenvironmentColon CancerLiquid biopsySequence Analysis RNACancerHigh-Throughput Nucleotide SequencingFibroblastsmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensPrognosisMicrovesiclesGene Expression Regulation Neoplastic030104 developmental biologyOncologyTumor microenvironmentTumor progressionCancer researchMolecular MedicineCancer-Associated FibroblastsColorectal Neoplasms
researchProduct

Potential Molecular Players of the Tumor Microenvironment in Extracranial Pediatric Solid Tumors

2020

Pediatric cancers are rare malignancies worldwide and represent around 1% of all new cancer diagnoses [...]

0301 basic medicineCancer ResearchTumor microenvironmentbusiness.industryCancermedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-28203 medical and health sciences030104 developmental biology0302 clinical medicineEditorialn/aOncology030220 oncology & carcinogenesisCancer researchMedicinebusinessCancers
researchProduct

Editorial: Cell Stress, Metabolic Reprogramming, and Cancer

2018

0301 basic medicineCancer Researchantioxidant responseAntioxidant response; Ataxia-telangiectasia mutated; Cancer; Epithelial-to-mesenchymal transition; Glutamine; Hypoxia-inducible factor 1 alpha; L-lactate; Mitochondria; Oncology; Cancer ResearchMetabolic reprogrammingMitochondrionBiologylcsh:RC254-28203 medical and health sciencesHypoxia-Inducible Factor 1-AlphamedicinecancerGlycolysisEpithelial–mesenchymal transitionataxia-telangiectasia mutatedCancerL-lactatemedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensGlutaminemitochondriaCell stress030104 developmental biologyEditorialOncologyCancer researchglutaminehypoxia-inducible factor 1 alphaepithelial-to-mesenchymal transition
researchProduct